Single nucleotide polymorphisms in clinics: Fantasy or reality for cancer?

References

• Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001;409:860–921
   PubMed Web of Science ®Google Scholar
• Gong G, Oakley-Girvan I, Wu AH, et al. Segregation analysis of prostate cancer in 1,719 white, African-American and Asian-American families in the United States and Canada. Cancer Causes Control 2002;13:471–82
   PubMed Web of Science ®Google Scholar
• The International HapMap C. A haplotype map of the human genome. Nature 2005;437:1299–320
   PubMed Web of Science ®Google Scholar
• HapMap. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007;449:851–61
   PubMed Web of Science ®Google Scholar
• McLeod HL. Cancer pharmacogenomics: early promise, but concerted effort needed. Science 2013;339:1563–6
   PubMed Web of Science ®Google Scholar
• Daly MB, Axilbund JE, Buys S, et al. Genetic/familial high-risk assessment: breast and ovarian. J Natl Compreh Cancer Netw 2010;8:562–94
   PubMed Web of Science ®Google Scholar
• Burt RW, Cannon JA, David DS, et al. Colorectal cancer screening. J Natl Compreh Cancer Netw 2013;11:1538–75
   PubMed Web of Science ®Google Scholar
• Eeles R, Goh C, Castro E, et al. The genetic epidemiology of prostate cancer and its clinical implications. Nat Rev Urol 2014;11:18–31
   PubMed Web of Science ®Google Scholar
• Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002;4:45–61
   PubMed Web of Science ®Google Scholar
• Todd JA. Statistical false positive or true disease pathway? Nat Genet 2006;38:731–3
   PubMed Web of Science ®Google Scholar
• Sham PC, Purcell SM. Statistical power and significance testing in large-scale genetic studies. Nat Rev Genet 2014;15:335–46
   PubMed Web of Science ®Google Scholar
• Ioannidis JP, Gwinn M, Little J, et al. A road map for efficient and reliable human genome epidemiology. Nat Genet 2006;38:3–5
   PubMed Web of Science ®Google Scholar
• Chang CQ, Yesupriya A, Rowell JL, et al. A systematic review of cancer GWAS and candidate gene meta-analyses reveals limited overlap but similar effect sizes. Eur J Hum Genet 2014;22:402–8
   PubMed Web of Science ®Google Scholar
• Gogele M, Minelli C, Thakkinstian A, et al. Methods for meta-analyses of genome-wide association studies: critical assessment of empirical evidence. Am J Epidemiol 2012;175:739–49
   PubMed Web of Science ®Google Scholar
• Stadler ZK, Thom P, Robson ME, et al. Genome-wide association studies of cancer. J Clin Oncol 2010;28:4255–67
   PubMed Web of Science ®Google Scholar
• Hoffmann TJ, Kvale MN, Hesselson SE, et al. Next generation genome-wide association tool: design and coverage of a high-throughput European-optimized SNP array. Genomics 2011;98:79–89
   PubMed Web of Science ®Google Scholar
• Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature 2009;461:747–53
   PubMed Web of Science ®Google Scholar
• Maher B. Personal genomes: the case of the missing heritability. Nature 2008;456:18–21
   PubMed Web of Science ®Google Scholar
• Eichler EE, Flint J, Gibson G, et al. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet 2010;11:446–50
   PubMed Web of Science ®Google Scholar
• Chatterjee N, Wheeler B, Sampson J, et al. Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies. Nat Genet 2013;45:400–5
   PubMed Web of Science ®Google Scholar
• Hindorff LA, Sethupathy P, Junkins HA, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Scie USA 2009;106:9362–7
   PubMed Web of Science ®Google Scholar
• Pooley KA, Bojesen SE, Weischer M, et al. A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk. Hum Mol Genet 2013;22:5056–64
   PubMed Web of Science ®Google Scholar
• Manolio TA. Bringing genome-wide association findings into clinical use. Nat Rev Genet 2013;14:549–58
   PubMed Web of Science ®Google Scholar
• Hindorff LA, Gillanders EM, Manolio TA. Genetic architecture of cancer and other complex diseases: lessons learned and future directions. Carcinogenesis 2011;32:945–54
   PubMed Web of Science ®Google Scholar
• Hardy J, Singleton A. Genomewide association studies and human disease. N Engl J Med 2009;360:1759–68
   PubMed Web of Science ®Google Scholar
• Welter D, MacArthur J, Morales J, et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucl Acids Res 2014;42:D1001–6
   PubMed Web of Science ®Google Scholar
• Eeles RA, Olama AA, Benlloch S, et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 2013;45:385–91, 91e1–2
   PubMed Web of Science ®Google Scholar
• Al Olama AA, Kote-Jarai Z, Berndt SI, et al. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat Genet 2014;46:1103–9
   PubMed Web of Science ®Google Scholar
• Kirk R. Genetics: the COGS are turning in breast, ovarian and prostate cancer. Nat Rev Clin Oncol 2013;10:245
   PubMedGoogle Scholar
• Michailidou K, Hall P, Gonzalez-Neira A, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 2013;45:353–61, 61e1–2
   PubMed Web of Science ®Google Scholar
• Bojesen SE, Pooley KA, Johnatty SE, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 2013;45:371–84, 84e1–2
   PubMed Web of Science ®Google Scholar
• Permuth-Wey J, Lawrenson K, Shen HC, et al. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun 2013;4:1627
   PubMed Web of Science ®Google Scholar
• Kote-Jarai Z, Saunders EJ, Leongamornlert DA, et al. Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Hum Mol Genet 2013;22:2520–8
   PubMed Web of Science ®Google Scholar
• Peterlongo P, Chang-Claude J, Moysich KB, et al. Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev 2015;24:308–16
   PubMed Web of Science ®Google Scholar
• Pharoah PD, Tsai YY, Ramus SJ, et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet 2013;45:362–70, 70e1–2
   PubMed Web of Science ®Google Scholar
• Spurdle AB, Thompson DJ, Ahmed S, et al. Genome-wide association study identifies a common variant associated with risk of endometrial cancer. Nat Genet 2011;43:451–4
   PubMed Web of Science ®Google Scholar
• Shi Y, Li L, Hu Z, et al. A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12. Nat Genet 2013;45:918–22
   PubMed Web of Science ®Google Scholar
• Chen D, Juko-Pecirep I, Hammer J, et al. Genome-wide association study of susceptibility loci for cervical cancer. J Natl Cancer Inst 2013;105:624–33
   PubMed Web of Science ®Google Scholar
• Schully SD, Yu W, McCallum V, et al. Cancer GAMAdb: database of cancer genetic associations from meta-analyses and genome-wide association studies. Eur J Hum Genet 2011;19:928–30
   PubMed Web of Science ®Google Scholar
• Barrdahl M, Canzian F, Joshi AD, et al. Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79 000 women. Hum Mol Genet 2014;23:5260–70
   PubMed Web of Science ®Google Scholar
• Cerhan JR, Berndt SI, Vijai J, et al. Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma. Nat Genet 2014;46:1233–8
   PubMed Web of Science ®Google Scholar
• Stegeman S, Amankwah E, Klein K, et al. A large scale analysis of genetic variants within putative miRNA binding sites in prostate cancer. Cancer Discov 2015;5:368–79
   Google Scholar
• Stegeman S, Amankwah E, Klein K, et al. Identification of a functional SNP in the 3'UTR of CXCR2 that is associated with reduced risk of lung cancer. Cancer Res 2015;7:566–75
   Google Scholar
• Tahara T, Okubo M, Shibata T, et al. Association between common genetic variants in pre-microRNAs and prognosis of advanced gastric cancer treated with chemotherapy. Anticancer Res 2014;34:5199–204
   Google Scholar
• Zhao Y, Wei Q, Hu L, et al. Polymorphisms in microRNAs are associated with survival in non-small cell lung cancer. Cancer Epidemiol Biomarkers Prev 2014;23:2503–11
   Google Scholar
• Liu S, An J, Lin J, Liu Y, Single nucleotide polymorphisms of microRNA processing machinery genes and outcome of hepatocellular carcinoma. PLoS One 2014;9:e92791
   Google Scholar
• Ryan BM, Robles AI, McClary AC, et al. Identification of a functional SNP in the 3'UTR of CXCR2 that is associated with reduced risk of lung cancer. Cancer Res 2015;75:566–75
   PubMed Web of Science ®Google Scholar
• Hebbring SJ. The challenges, advantages and future of phenome-wide association studies. Immunology 2014;141:157–65
   PubMed Web of Science ®Google Scholar
• Denny JC, Ritchie MD, Basford MA, et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics 2010;26:1205–10
   PubMed Web of Science ®Google Scholar
• Bilder RM, Sabb FW, Cannon TD, et al. Phenomics: the systematic study of phenotypes on a genome-wide scale. Neuroscience 2009;164:30–42
   PubMed Web of Science ®Google Scholar
• Denny JC, Bastarache L, Ritchie MD, et al. Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat Biotechnol 2013;31:1102–10
   PubMed Web of Science ®Google Scholar
• Roberts NJ, Vogelstein JT, Parmigiani G, et al. The predictive capacity of personal genome sequencing. Sci Transl Med 2012;4:133ra58
   PubMed Web of Science ®Google Scholar
• Shah S, Schrader KA, Waanders E, et al. A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia. Nat Genet 2013;45:1226–31
   PubMed Web of Science ®Google Scholar
• Enciso-Mora V, Hosking FJ, Houlston RS. Risk of breast and prostate cancer is not associated with increased homozygosity in outbred populations. Eur J Hum Genet 2010;18:909–14
   PubMed Web of Science ®Google Scholar
• Saarinen S, Aavikko M, Aittomaki K, et al. Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphoma. Blood 2011;118:493–8
   PubMed Web of Science ®Google Scholar
• Yokoyama S, Woods SL, Boyle GM, et al. A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature 2011;480:99–103
   PubMed Web of Science ®Google Scholar
• Tomlinson I. Colorectal cancer genetics: from candidate genes to GWAS and back again. Mutagenesis 2012;27:141–2
   PubMed Web of Science ®Google Scholar
• Sur IK, Hallikas O, Vaharautio A, et al. Mice lacking a Myc enhancer that includes human SNP rs6983267 are resistant to intestinal tumors. Science 2012;338:1360–3
   PubMed Web of Science ®Google Scholar
• Relling MV, Gardner EE, Sandborn WJ, et al. Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clin Pharmacol Ther 2011;89:387–91
   PubMed Web of Science ®Google Scholar
• Evans JP, Meslin EM, Marteau TM, Caulfield T. Genomics. Deflating the genomic bubble. Science 2011;331:861–2
   PubMed Web of Science ®Google Scholar
• Manolio TA, Chisholm RL, Ozenberger B, et al. Implementing genomic medicine in the clinic: the future is here. Genet Med 2013;15:258–67
   PubMed Web of Science ®Google Scholar
• Walraven JM, Trent JO, Hein DW. Structure-function analyses of single nucleotide polymorphisms in human N-acetyltransferase 1. Drug Metab Rev 2008;40:169–84
   PubMed Web of Science ®Google Scholar
• Walraven JM, Zang Y, Trent JO, Hein DW. Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2. Curr Drug Metab 2008;9:471–86
   PubMed Web of Science ®Google Scholar
• Song F, Ji P, Zheng H, et al. Definition of a functional single nucleotide polymorphism in the cell migration inhibitory gene MIIP that affects the risk of breast cancer. Cancer Res 2010;70:1024–32
   PubMed Web of Science ®Google Scholar
• Yamtich J, Nemec AA, Keh A, Sweasy JB. A germline polymorphism of DNA polymerase beta induces genomic instability and cellular transformation. PLoS Genetics 2012;8:e1003052
   Google Scholar
• Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res 2001;11:863–74
   PubMed Web of Science ®Google Scholar
• Thomas PD, Campbell MJ, Kejariwal A, et al. PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 2003;13:2129–41
   PubMed Web of Science ®Google Scholar
• Sunyaev S, Lathe W, III Bork, P. Integration of genome data and protein structures: prediction of protein folds, protein interactions and “molecular phenotypes” of single nucleotide polymorphisms. Curr Opin Struct Biolo 2001;11:125–30
   PubMed Web of Science ®Google Scholar
• Bromberg Y, Rost B. SNAP: predict effect of non-synonymous polymorphisms on function. Nucl Acids Res 2007;35:3823–35
   PubMed Web of Science ®Google Scholar
• Capriotti E, Calabrese R, Casadio R. Predicting the insurgence of human genetic diseases associated to single point protein mutations with support vector machines and evolutionary information. Bioinformatics 2006;22:2729–34
   PubMed Web of Science ®Google Scholar
• Clements JA, Willemsen NM, Myers SA, Dong Y. The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers. Crit Rev Clin Lab Sci 2004;41:265–312
   PubMed Web of Science ®Google Scholar
• Lawrence MG, Lai J, Clements JA. Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus. Endocr Rev 2010;31:407–46
   PubMed Web of Science ®Google Scholar
• Gao L, Smith RS, Chen LM, et al. Tissue kallikrein promotes prostate cancer cell migration and invasion via a protease-activated receptor-1-dependent signaling pathway. Biol Chem 2010;391:803–12
   PubMed Web of Science ®Google Scholar
• Ishii K, Otsuka T, Iguchi K, et al. Evidence that the prostate-specific antigen (PSA)/Zn2+ axis may play a role in human prostate cancer cell invasion. Cancer Lett 2004;207:79–87
   PubMed Web of Science ®Google Scholar
• Kote-Jarai Z, Amin Al Olama A, Leongamornlert D, et al. Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript. Hum Genet 2011;129:687–94
   PubMed Web of Science ®Google Scholar
• Innocenti F. One SNP for both cancer risk and survival in colorectal cancer: two for the price of one? Pharmacogenomics 2012;13:1114
   PubMed Web of Science ®Google Scholar
• Li G, Bahn JH, Lee JH, et al. Identification of allele-specific alternative mRNA processing via transcriptome sequencing. Nucl Acids Res 2012;40:e104
   Google Scholar
• Maurano MT, Humbert R, Rynes E, et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012;337:1190–5
   PubMed Web of Science ®Google Scholar
• Nicolae DL, Gamazon E, Zhang W, et al. Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet 2010;6:e1000888
   PubMed Web of Science ®Google Scholar
• Dimas AS, Deutsch S, Stranger BE, et al. Common regulatory variation impacts gene expression in a cell type-dependent manner. Science 2009;325:1246–50
   PubMed Web of Science ®Google Scholar
• Kim HS, Minna JD, White MA. GWAS meets TCGA to illuminate mechanisms of cancer predisposition. Cell 2013;152:387–9
   PubMed Web of Science ®Google Scholar
• Bryois J, Buil A, Evans DM, et al. Cis and trans effects of human genomic variants on gene expression. PLoS Genet 2014;10:e1004461
   PubMed Web of Science ®Google Scholar
• Fu J, Wolfs MG, Deelen P, et al. Unraveling the regulatory mechanisms underlying tissue-dependent genetic variation of gene expression. PLoS Genet 2012;8:e1002431
   PubMed Web of Science ®Google Scholar
• Koopmann TT, Adriaens ME, Moerland PD, et al. Genome-wide identification of expression quantitative trait loci (eQTLs) in human heart. PloS One 2014;9:e97380
   Google Scholar
• Kulkarni S, Savan R, Qi Y, et al. Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 2011;472:495–8
   PubMed Web of Science ®Google Scholar
• Cunnington MS, Santibanez Koref M, et al. Chromosome 9p21 SNPs associated with multiple disease phenotypes correlate with ANRIL expression. PLoS Genet 2010;6:e1000899
   Web of Science ®Google Scholar
• Grisanzio C, Werner L, Takeda D, et al. Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis. Proc Natl Acad Sci USA 2012;109:11252–7
   PubMed Web of Science ®Google Scholar
• Kwan T, Benovoy D, Dias C, et al. Genome-wide analysis of transcript isoform variation in humans. Nat Genet 2008;40:225–31
   PubMed Web of Science ®Google Scholar
• McVicker G, van de Geijn B, Degner JF, et al. Identification of genetic variants that affect histone modifications in human cells. Science 2013;342:747–9
   PubMed Web of Science ®Google Scholar
• Kasowski M, Kyriazopoulou-Panagiotopoulou S, Grubert F, et al. Extensive variation in chromatin states across humans. Science 2013;342:750–2
   PubMed Web of Science ®Google Scholar
• Kilpinen H, Waszak SM, Gschwind AR, et al. Coordinated effects of sequence variation on DNA binding, chromatin structure, and transcription. Science 2013;342:744–7
   PubMed Web of Science ®Google Scholar
• Kasowski M, Grubert F, Heffelfinger C, et al. Variation in transcription factor binding among humans. Science 2010;328:232–5
   PubMed Web of Science ®Google Scholar
• Degner JF, Pai AA, Pique-Regi R, et al. DNase I sensitivity QTLs are a major determinant of human expression variation. Nature 2012;482:390–4
   PubMed Web of Science ®Google Scholar
• Shen H, Fridley BL, Song H, et al. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun 2013;4:1628
   PubMed Web of Science ®Google Scholar
• Patnala R, Clements J, Batra J. Candidate gene association studies: a comprehensive guide to useful in silico tools. BMC Genet 2013;14:39
   PubMed Web of Science ®Google Scholar
• Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009;458:223–7
   PubMed Web of Science ®Google Scholar
• Djebali S, Davis CA, Merkel A, et al. Landscape of transcription in human cells. Nature 2012;489:101–8
   PubMed Web of Science ®Google Scholar
• Ernst S, Kirchner S, Krellner C, et al. Emerging local Kondo screening and spatial coherence in the heavy-fermion metal YbRh2Si2. Nature 2011;474:362–6
   PubMed Web of Science ®Google Scholar
• Heintzman ND, Hon GC, Hawkins RD, et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009;459:108–12
   PubMed Web of Science ®Google Scholar
• Ernst J, Kellis M. Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat Biotechnol 2010;28:817–25
   PubMed Web of Science ®Google Scholar
• Gavrilov A, Eivazova E, Priozhkova I, et al. Chromosome conformation capture (from 3C to 5C) and its ChIP-based modification. Methods Mol Biol 2009;567:171–88
   PubMedGoogle Scholar
• van Berkum NL, Dekker J. Determining spatial chromatin organization of large genomic regions using 5C technology. Methods Mol Biol 2009;567:189–213
   PubMedGoogle Scholar
• Fullwood MJ, Ruan Y. ChIP-based methods for the identification of long-range chromatin interactions. J Cell Biochem 2009;107:30–9
   PubMed Web of Science ®Google Scholar
• Sanyal A, Lajoie BR, Jain G, Dekker J. The long-range interaction landscape of gene promoters. Nature 2012;489:109–13
   PubMed Web of Science ®Google Scholar
• Tomlinson I, Webb E, Carvajal-Carmona L, et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 2007;39:984–8
   PubMed Web of Science ®Google Scholar
• Pomerantz MM, Ahmadiyeh N, Jia L, et al. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet 2009;41:882–4
   PubMed Web of Science ®Google Scholar
• Pomerantz MM, Beckwith CA, Regan MM, et al. Evaluation of the 8q24 prostate cancer risk locus and MYC expression. Cancer Res 2009;69:5568–74
   PubMed Web of Science ®Google Scholar
• Jia L, Landan G, Pomerantz M, et al. Functional enhancers at the gene-poor 8q24 cancer-linked locus. PLoS Genet 2009;5:e1000597
   PubMedGoogle Scholar
• Al Olama AA, Kote-Jarai Z, Giles GG, et al. Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet 2009;41:1058–60
   PubMed Web of Science ®Google Scholar
• Cropp CD, Robbins CM, Sheng X, et al. 8q24 risk alleles and prostate cancer in African-Barbadian men. Prostate 2014;74:1579–88
   PubMed Web of Science ®Google Scholar
• Ahmadiyeh N, Pomerantz MM, Grisanzio C, et al. 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proc Natl Acad Sci USA 2010;107:9742–6
   PubMed Web of Science ®Google Scholar
• Kote-Jarai Z, Leongamornlert D, Tymrakiewicz M, et al. Mutation analysis of the MSMB gene in familial prostate cancer. Br J Cancer 2010;102:414–18
   PubMed Web of Science ®Google Scholar
• Whitaker HC, Kote-Jarai Z, Ross-Adams H, et al. The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine. PloS One 2010;5:e13363
   Google Scholar
• Whitaker HC, Warren AY, Eeles R, et al. The potential value of microseminoprotein-beta as a prostate cancer biomarker and therapeutic target. Prostate 2010;70:333–40
   PubMed Web of Science ®Google Scholar
• Charles BA, Shriner D, Rotimi CN. Accounting for linkage disequilibrium in association analysis of diverse populations. Genet Epidemiol 2014;38:265–73
   PubMed Web of Science ®Google Scholar
• Haiman CA, Stram DO. Exploring genetic susceptibility to cancer in diverse populations. Curr Opin Genet Dev 2010;20:330–5
   PubMed Web of Science ®Google Scholar
• Peprah E, Xu H, Tekola-Ayele F, Royal CD. Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease. Public Health Genomics 2015;18:40–51
   PubMed Web of Science ®Google Scholar
• Zhang B, Jia WH, Matsuda K, et al. Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk. Nat Genet 2014;46:533–42
   PubMed Web of Science ®Google Scholar
• Matsuda K, Takahashi A, Middlebrooks CD, et al. Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population. Hum Mol Genet 2015;24:1177–84
   PubMed Web of Science ®Google Scholar
• Feng Y, Stram DO, Rhie SK, et al. A comprehensive examination of breast cancer risk loci in African American women. Hum Mol Genet 2014;23:5518–26
   PubMed Web of Science ®Google Scholar
• Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9–29
   PubMed Web of Science ®Google Scholar
• Zheng SL, Sun J, Wiklund F, et al. Cumulative association of five genetic variants with prostate cancer. N Engl J Med 2008;358:910–19
   PubMed Web of Science ®Google Scholar
• Lovett KM, Liang BA, Mackey TK. Risks of online direct-to-consumer tumor markers for cancer screening. J Clin Oncol 2012;30:1411–14
   PubMed Web of Science ®Google Scholar
• Jose S. Future of Direct-to-Consumer (DTC) Genetic Testing Market Remains Fraught with Challenges, According to New Report by Global Industry Analysts, Inc. San Jose (CA): Global Industry Analysts, Inc.; 2012
   Google Scholar
• Meyer UA. Pharmacogenetics – five decades of therapeutic lessons from genetic diversity. Nat Rev Genet 2004;5:669–76
   PubMed Web of Science ®Google Scholar
• Alavijeh MS, Chishty M, Qaiser MZ, Palmer AM. Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery. NeuroRx 2005;2:554–71
   PubMedGoogle Scholar
• Vourvahis M, Kashuba AD. Mechanisms of pharmacokinetic and pharmacodynamic drug interactions associated with ritonavir-enhanced tipranavir. Pharmacotherapy 2007;27:888–909
   PubMed Web of Science ®Google Scholar
• Preissner S, Dunkel M, Hoffmann MF, et al. Drug cocktail optimization in chemotherapy of cancer. PloS One 2012;7:e51020
   PubMedGoogle Scholar
• Huttunen KM, Mahonen N, Raunio H, Rautio J. Cytochrome P450-activated prodrugs: targeted drug delivery. Curr Med Chem 2008;15:2346–65
   PubMed Web of Science ®Google Scholar
• Iyer L, Das S, Janisch L, et al. UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity. Pharmacogen J 2002;2:43–7
   PubMedGoogle Scholar
• Hoskins JM, Goldberg RM, Qu P, et al. UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters. J Natl Cancer Inst 2007;99:1290–5
   PubMed Web of Science ®Google Scholar
• Wong A, Soo RA, Yong WP, Innocenti F. Clinical pharmacology and pharmacogenetics of gemcitabine. Drug Metab Rev 2009;41:77–88
   PubMed Web of Science ®Google Scholar
• Innocenti F, Undevia SD, Iyer L, et al. Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. J Clin Oncol 2004;22:1382–8
   PubMed Web of Science ®Google Scholar
• Rosenstein BS. Identification of SNPs associated with susceptibility for development of adverse reactions to radiotherapy. Pharmacogenomics 2011;12:267–75
   PubMed Web of Science ®Google Scholar
• Zhang L, Gao G, Li X, et al. Association between single nucleotide polymorphisms (SNPs) and toxicity of advanced non-small-cell lung cancer patients treated with chemotherapy. PLoS One 2012;7:e48350
   PubMed Web of Science ®Google Scholar
• Mehrotra N, Gupta M, Kovar A, Meibohm B. The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy. Int J Impot Res 2007;19:253–64
   PubMed Web of Science ®Google Scholar
• Tutt A, Robson M, Garber JE, et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet 2010;376:235–44
   PubMed Web of Science ®Google Scholar
• Leandro-Garcia LJ, Leskela S, Jara C, et al. Regulatory polymorphisms in beta-tubulin IIa are associated with paclitaxel-induced peripheral neuropathy. Clin Cancer Res 2012;18:4441–8
   PubMed Web of Science ®Google Scholar
• Abraham JE, Guo Q, Dorling L, et al. Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with Paclitaxel. Clin Cancer Res 2014;20:2466–75
   PubMed Web of Science ®Google Scholar
• Baldwin RM, Owzar K, Zembutsu H, et al. A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101. Clin Cancer Res 2012;18:5099–109
   PubMed Web of Science ®Google Scholar
• Loriot Y, Perlemuter G, Malka D, et al. Drug insight: gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapy. Nat Clin Pract Oncol 2008;5:268–78
   PubMedGoogle Scholar
• Ingle JN, Schaid DJ, Goss PE, et al. Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors. J Clin Oncol 2010;28:4674–82
   PubMed Web of Science ®Google Scholar
• Wu X, Ye Y, Rosell R, et al. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. J Natl Cancer Inst 2011;103:817–25
   PubMed Web of Science ®Google Scholar
• Ohira T, Arita M, Omori K, et al. Resolvin E1 receptor activation signals phosphorylation and phagocytosis. J Biol Chem 2010;285:3451–61
   PubMed Web of Science ®Google Scholar
• Kaur J, Adya R, Tan BK, et al. Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis. Biochem Biophys Res Commun 2010;391:1762–8
   PubMed Web of Science ®Google Scholar
• Hertz DL, McLeod HL. Using pharmacogene polymorphism panels to detect germline pharmacodynamic markers in oncology. Clin Cancer Res 2014;20:2530–40
   PubMed Web of Science ®Google Scholar
• John EM, Miron A, Gong G, et al. Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA. 2007;298:2869–76
   PubMed Web of Science ®Google Scholar